Drug – bio-affecting and body treating compositions – Antigen – epitope – or other immunospecific immunoeffector – Amino acid sequence disclosed in whole or in part; or...
Reexamination Certificate
2002-06-18
2008-09-02
Duffy, Patricia A (Department: 1645)
Drug, bio-affecting and body treating compositions
Antigen, epitope, or other immunospecific immunoeffector
Amino acid sequence disclosed in whole or in part; or...
C424S192100, C530S324000, C530S350000
Reexamination Certificate
active
07419671
ABSTRACT:
The present invention provides an antigenic composition, the composition comprising at least one recombinant protein. The recombinant protein comprises at least one epitope. The epitope is reactive with an antibody which is reactive with a polypeptide having the sequence set out in SEQ. ID. NO. 3 or SEQ. ID. NO. 5. The invention also provides methods and compositions for the production of the recombinant protein. Also provided are methods for the diagnosis, treatment and prevention ofP. gingivalisinfection.
REFERENCES:
patent: 4603112 (1986-07-01), Paoletti et al.
patent: 4735801 (1988-04-01), Stocker
patent: 4837151 (1989-06-01), Stocker
patent: 5210035 (1993-05-01), Stocker
patent: 5824791 (1998-10-01), Progulske-Fox et al.
patent: 6511666 (2003-01-01), Reynolds et al.
patent: WO 95/07286 (1995-03-01), None
patent: WO 96/17936 (1996-06-01), None
patent: WO 97/16542 (1997-05-01), None
patent: WO-97/34629 (1997-09-01), None
Sequence alingment: Acc# AAR96033.
Sequence alingment: Acc# AAW69495.
Sequence alingment: for patentt # 6511666.
Rangarajan et al (Molecular Microbiology, 23(5):955-965, 1997).
Campbell, A.M. (Monoclonal Antibody Technology, Chapter 1, pp. 1-32, Elsevier Science Publishing Company, Inc. NY, NY, 1984).
Harlow et al (Antibodies: A Laboratory Manual, Cold Spring Harbor Press Inc., 1988, pp. 56-58, 72, 88-92 and 96-97).
American Type Culture Collection Catalogue 1989, p. 39.
Slakeski et al (Biocehmical and Biophysical Research Communications, 224:605-610, 1996).
Salkeski et al (Biochemical and Biophysical Research Communications 207(1):424-431, 1995).
Zeitlin et al (Emerging Infectious Diseases, 5:54-64, 1999).
Dorlands Medical Dictionary, definition of gingiva.
Stedman's Medical Dictionary, definition of gingiva.
GenBank Accession No. AF175715, Aug. 23, 1999, located at <http://www.ncbi.nlm.nih.gov/entrez/qwuery.fcgi?cmd=Retrieve&db=nucleotide&list?> visited Aug. 27, 2002. (2 pages.).
Aduse-Opoku, J. et al. (1995). “Characterization, Genetic Analysis, and Expression of a Protease Antigen (PrpRI) ofPorphyromonas gingivalisW50,”Infection and Immunity63(12):4744-4754.
Barkocy-Gallagher, G.A. et al. (1996). “Analysis of theprtPGene Encoding Porphypain, a Cysteine Proteinase ofPorphyromonas gingivalis,” Journal of Bacteriology178(10): 2734-2741.
Beck, J. et al. (1996). “Periodontal Disease and Cardiovascular Disease,”J. Periodontol.67: 1123-1137.
Beck, J.D. et al. (1998). “Periodontitis: A Risk Factor for Coronary Heart Disease?”Annals of Periodontology3(1): 127-141.
Bhogal, P.S. et al. (1997). “A Cell-Associated Protein Complex ofPorphyromonas gingivalisW50 Composed of Arg- and Lys-specific Cysteine Proteinases and Adhesins,”Microbiology143: 2485-2495.
Cox, J.C. and Coulter, A. R. (1992). “Advances in Adjuvant Technology and Application,” Chapter 4In Animals Parasite Control Utilizing Technology, Wong, W.K. ed. CRC Press: Boca Raton, FL. pp. 49-112.
Curtiss, R. III et al. (1988). “A virulentSalmonella typhimurium Δcya ΔcrpOral Vaccine Strains Expressing a Streptococcal Colonization and Virulence Antigen,”Vaccine. 6: 155-160.
Dryland, A. et al. (1986). “Peptide Synthesis. Part 8. A System for Solid-Phase Synthesis Under Low Pressure Continuous Flow Conditions,”J. Chem. Soc. Perkin Trans.I: 125-137.
Fynan, E.F. et al. (1993). “DNA Vaccines: Protective Immunizations By Parenteral, Mucosal, and Gene-Gun Inoculations,”Proc. Natl. Acad. Sci. USA. 90: 11478-11482.
Geysen, H. M. et al. (1987). “Strategies for Epitope Analysis Using Peptide Synthesis,”Journal of Immunological Methods. 102: 259-274.
Geysen, H. M. et al. (1984). “Use of Peptide Synthesis to Probe Viral Antigens For Epitopes to a Resolution of a Single Amino Acid,”Proc. Natl. Acad. Sci. USA. 81: 3998-4002.
Lewis, J.P. and Macrina, F. L. (1998). “ISI95, an Insertion Sequence-Like Element Associated with Protease Genes inPorphyromonas gingivalis,” Infection and Immunity66(7): 3035-3042.
Macario, A.J.L. and deMacario, E.C. eds. (1990).Gene Probes for Bacteria. Academic Press: New York, NY pp. vii-xii (Table of Contents).
Mitchell, A.R. et al. (1978). “A New Synthetic Route totert-Butyloxycarbonylaminoacyl-4-(oxymethyl) phenylacetamidomethyl-resin, an Improved Support for Solid-Phase Peptide Synthesis,”J. Org. Chem.43(14): 2845-2852.
Shibata, Y. et al. (1999). “Determination and Characterization of the Hemagglutinin-Associated Short Motifs Found inPorphyromonas gingivalisMultiple Gene Products,”The Journal of Biological Chemistry274(8): 5012-5020.
Thorpe's Dictionary of Applied Chemistry, vol. 9, 4thEdition. pp. 510-511.
Zhu, N. et al. (1993). “Systemic Gene Expression After Intravenous DNA Delivery into Adult Mice,”Science. 261: 209-211.
Supplementary Partial European Search Report mailed on May 24, 2005, for EP Application No. 00986886.0, four pages.
American Dental Association. “Oral Health Topics A-Z:Periodontal (Gum) Disease-FAQ,” located at <http://www.ada.org/public/topics/periodontal—diseases—faq.asp>last visited on Mar. 28, 2006. (3 pages).
American Dental Association. “Oral Health Topics A-Z:Periodontal (Gum) Diseases,” located at <http://www.ada.org/public/topics/periodontal—diseases.asp>last visited on Mar. 28, 2006. (2 pages).
O'Brien-Simpson, N.M. et al. (2005). “An Immune Response Directed to Proteinase and Adhesin Functional Epitopes Protects againstPorphyromonas gingivalis-Induced Periodontal Bone Loss,”Journal of Immunol.175(6):3980-3989.
Baker, P.J. et al. (2000). “Heterogeneity ofPorphyromonas gingivalisStrains in the Induction of Alveolar Bone Loss in Mice,”Oral Microbiol Immunol.15:27-32.
Ebersole, J.L. et al. (1995). “Comparative Virulence of Periodontopathogens in a Mouse Abscess Model,”Oral Diseases1:115-128.
Evans, R.T. et al. (1992). “Periodontopathic Potential of Two Strains ofPorphyromonas gingivalisin Gnotobiotic Rats,”Arch Oral Biol.37(10):813-819.
Griffen, A.L. et al. (Dec. 1999). “Porphyromonas gingivalisStrain Variability and Periodontitis,”Journal of Clinical Microbiology37(12):4028-4033.
Hernandez, V.G. et al. (1989). “Clinical and Clinico-Histological Markers in Chronic Destructive Adult Periodontitis,”Av Periodoncia1(1):33-43. [Article in Spanish]. Pub Med English Abstract located at <http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=pubmed&cmd=Retrieve&dopt=AbstractPlus&list—uids=16148146&query—hl=3&itool=pubmed—docsum>, last visited on Jan. 25, 2007, one page.
Kesavalu, L. et al. (1996). “Trypsin-like Protease Activity ofPorphyromonas gingivalisas a Potential Virulence Factor in a Murine Lesion Model,”Microbial Pathogenesis20:1-10.
Liu, R.K. et al. (Nov. 2001). “Polymorphonuclear Neutrophils and Their Mediators in Gingival Tissues From Generalized Aggressive Periodontitis,”J. Periodontol72(11):1545-1553.
Marsh, P.D. et al. (1994). “The Effect of Growth Rate and Haemin on the Virulence and Proteolytic Activity ofPorphyromonas gingivalisW50,”Microbiology140:861-865.
Neiders, M.E. et al. (1989). “Heterogeneity of Virulence Among Strains ofBacteroides gingivalis,” J. Periodont Res.24:192-198.
O'Brien-Simpson, N.M. et al. (2005). “An Immune Response Directed to Proteinase and Adhesin Functional Epitopes Protects AgainstPorphyromonas gingivalis-Induced Periodontal Bone Loss,”Journal of Immunology175(6): 3980-3989.
O'Brien-Simpson, N.M. et al. (Dec. 2001). “Role of RgpA, RgpB, and Kgp Proteinases in Virulence ofPorphyromonas gingivalisW50 in a Murine Lesion Model,”Infection and Immunity69(12):7527-7534.
Schifferle, R.E. et al. (1993). “Modification of ExperimentalPorphyromonas gingivalisMurine Infection by Immunization with a Polysaccharide-Protein
Barr Ian George
Chen Chao Guang
Reynolds Eric Charles
Slakeski Nada
CSL Limited
Duffy Patricia A
Morrison & Foerster / LLP
The University of Melbourne
LandOfFree
P. gingivalis antigenic composition does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with P. gingivalis antigenic composition, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and P. gingivalis antigenic composition will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3975867